Status:
COMPLETED
Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Chronic Angle Closure Glaucoma
Primary Angle Closure
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
Sequential Laser Iridotomy uses argon and Nd:yag laser in the first and second steps, respectively. Using q-switched 532 nm laser in the second step is hypothesized to be as good and effective as the ...
Detailed Description
Laser iridotomy is an established procedure in the management of angle closure glaucoma (ACG) and for prophylaxis in the fellow eyes. Sequential argon-YAG (SAY) laser iridotomy is the serial use of a...
Eligibility Criteria
Inclusion
- More than 21 years old
- Able to give informed consent
- Diagnosis of either: chronic angle closure glaucoma (CACG), primary angle closure (PAC), primary angle closure suspect (PACS) or fellow eyes of acute angle closure glaucoma (AACG), and in need of a laser iridotomy
Exclusion
- History of any prior laser treatment or intraocular surgery to the eye
- History of any corneal disease
- Any ocular infection/ inflammation within the last two months
- Inability to give informed consent
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00452998
Start Date
November 1 2006
End Date
December 1 2007
Last Update
May 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, 119074